Biotech Series A Investors & VC Firms
1654 firms in this list, with a median first check of $500K. 363 of them lead rounds. Generated from verified public data and updated continuously.
Y Combinator
San FranciscoPre-Seed–Series A$500K
22 people
Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
109 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
67 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
56 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
104 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
57 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
42 people
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
117 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
48 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
26 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
38 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
54 people
Felicis Ventures
San FranciscoPre-Seed–Series B$500K – $15M
46 people
DCVC (Data Collective)
Palo AltoPre-Seed–Late Stage$5M – $25M
47 people
Canaan Partners
StamfordPre-Seed–Series A$500K – $20M
34 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
69 people
Draper Associates
San MateoPre-Seed–Series A$500K – $5M
20 people
Elevate Ventures
IndianapolisPre-Seed–Growth$20K – $2M
28 people
Menlo Ventures
San FranciscoPre-Seed–Growth$1M – $20M
49 people
Capria Ventures
BengaluruSeed–Late Stage$300K – $1M
27 people
8VC
AustinPre-Seed–Late Stage$100K – $50M
48 people
Octopus Ventures
LondonPre-Seed–Late Stage$130K – $1.3M
75 people
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
88 people
Qiming Venture Partners
BeijingSeed–Growth$5M – $134M
8 people
Frequently asked questions
- Who are the top biotech series a investors & vc firms?
- Top biotech series a investors & vc firms include Y Combinator, Andreessen Horowitz, New Enterprise Associates (NEA), Bessemer Venture Partners, F-Prime Capital, Khosla Ventures, Sequoia Capital, OrbiMed — 1654 firms in total meet the criteria.
- What is the typical first check among biotech series a investors & vc firms?
- The median first check among the 1654 biotech series a investors & vc firms tracked here is $500K.
- How many biotech series a investors & vc firms lead rounds?
- 363 of the 1654 biotech series a investors & vc firms tracked here lead investment rounds.
Related lists
Series A Investors & VC Firms (8102)Series A Investors & VC Firms in North America (4560)Series A Investors & VC Firms in United States (4148)SaaS Series A Investors & VC Firms (2839)Series A Investors & VC Firms in Europe (2586)AI & Machine Learning Series A Investors & VC Firms (2481)Enterprise Software Series A Investors & VC Firms (2403)Fintech Series A Investors & VC Firms (2382)Healthtech Series A Investors & VC Firms (2346)Series A Investors & VC Firms in Global (2246)
Data sourced from public filings and firms' own websites — see our methodology.


































.png)






















%20copy.jpg)






































